
Cause disparities in coronary heart disease between genders
- 1 Archbishop Mitty High School, CA, USA
* Author to whom correspondence should be addressed.
Abstract
Limited studies investigated the differences between the causes of coronary heart disease in men and women. While some focused on one gender or the other, minimal studies indeed examined the differences in the significance of each of the common risk factors present in both genders. Thus, this study intends to do just that. This study uses data from the Framingham Heart Study, a long-term cardiovascular cohort study of the residents of Framingham, Massachusetts. A variety of factors were considered in examining the risk of coronary heart disease, including gender, age, and previous medical history. Exploratory data analysis and regression analysis were used to reveal the differences between men and women in determining the risk of coronary heart disease. Through regression analysis, apparent differences between males and females arose. Significant factors for men included age, systolic blood pressure, total cholesterol, and glucose levels, and significant factors for women additionally included the number of cigarettes smoked per day as well as a previous history of hypertension. The Framingham Heart Study has demonstrated the distinctions between men and women when it comes to the risks of coronary heart disease, allowing physicians to gain a deeper understanding of the disease. However, it fails to be inclusive of all races and ethnicities as participants in the first cohort and many later cohorts of the study were all Caucasian. This study also calls for future studies to build off the Framingham Heart Study’s shortcomings and provide data and standards suitable for everyone.
Keywords
coronary heart disease, genders, significant factors, distinctions
[1]. Sanchis-Gomar F, Perez-Quilis C, Leischik R, and Lucia A 2016 Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 4(13):256.
[2]. Kannel WB 1990 Bishop lecture. Contribution of the Framingham Study to preventive cardiology. 15(1):206-11
[3]. Mahmood SS, Levy D, Vasan RS, and Wang TJ 2014 The Framingham Heart Study and the Epidemiology of Cardiovascular Diseases: A Historical Perspective. Lancet. 383:999-1008
[4]. Hajar R 2017 Risk Factors for Coronary Artery Disease: Historical Perspectives. Heart Views. 18(3):109-114
[5]. Ulbricht TL and Southgate DA 1991 Coronary heart disease: seven dietary factors. Lancet. 338(8773):985-92
[6]. Maas AH and Appelman YE 2010 Gender differences in coronary heart disease. Neth Heart J. 18(12):598-602
[7]. Murabito JM 1995 Women and cardiovascular disease: contributions from the Framingham Heart Study. J Am Med Womens Assoc1972). 50(2):35-9
[8]. Khayyam-Nekouei Z, Neshatdoost H, Yousefy A, Sadeghi M, and Manshaee G 2013 Psychological factors and coronary heart disease. ARYA Atheroscler. 9(1):102-111
[9]. Pathak LA, Shirodkar S, Ruparelia R, and Rajebahadur J 2017 Coronary artery disease in women. Indian Heart J. 69(4):532-538
[10]. Kuller LH 2010 Cardiovascular disease is preventable among women. Expert Rev Cardiovasc Ther. 8(2):175-87
[11]. Saeed A, Kampangkaew J, and Nambi V 2017 Prevention of Cardiovascular Disease in Women. Methodist Debakey Cardiovasc J. 13(4):185-192
[12]. Mann GV, Garrett HL, Farhi A, Murray H, and Billings FT 1969 Exercise to prevent coronary heart disease. An experimental study of the effects of training on risk factors for coronary disease in men. Am J Med. 46(1):12-27
[13]. Andersson C, Johnson AD, Benjamin EJ, Levy D, and Vasan RS 2019 70-year legacy of the Framingham Heart Study. Nat Rev Cardiol. 16(11):687-698
[14]. Andersson C, Nayor M, Tsao CW, Levy D, and Vasan RS 2021 Framingham Heart Study. JACC Focus Seminar, 1/8. J Am Coll Cardiol. 77(21):2680-2692
[15]. Tsao CW, and Vasan RS 2015 Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol. 44(6):1800-13
Cite this article
Shen,I. (2024). Cause disparities in coronary heart disease between genders. Theoretical and Natural Science,62,33-39.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 4th International Conference on Biological Engineering and Medical Science
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).